Related Experiment Video
Updated: Nov 6, 2025

07:47
Transplantation of a 3D Bioprinted Patch in a Murine Model of Myocardial Infarction
Published on: September 26, 2020
6.8K
Recent advances in bioprinting technologies for engineering cardiac tissue
Tarun Agarwal1, Gabriele Maria Fortunato2, Sung Yun Hann3
1Department of Biotechnology, Indian Institute of Technology Kharagpur, West Bengal 721302, India.
Summary
Researchers are advancing bioprinting for cardiac tissue engineering to address heart disease. This review covers engineered cardiac tissue fabrication, materials, cells, and personalized medicine for regenerative therapies.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cardiovascular Research
Background:
- Increasing incidence of cardiac disorders necessitates novel therapeutic strategies due to limited cardiac tissue regeneration.
- Bioprinting technologies offer promising avenues for creating engineered functional cardiac tissue models.
- These models are valuable for both regenerative medicine and diagnostic applications.
Purpose of the Study:
- To review recent advancements in engineered cardiac tissue fabrication using bioprinting.
- To highlight various printing ink formulations and cellular options for cardiac tissue engineering.
- To discuss the role of personalized medicine in cardiac tissue bioprinting.
Main Methods:
- Review of traditional and advanced bioprinting strategies for cardiac tissue.
- Analysis of bio-ink formulations and cell sources used in cardiac tissue engineering.
- Exploration of personalized medicine approaches in cardiac bioprinting.
Main Results:
- Bioprinting technologies have significantly advanced, enabling the creation of engineered cardiac tissues.
- Diverse bio-inks and cell types are being explored for improved cardiac tissue functionality.
- Personalized medicine approaches are being integrated into cardiac tissue engineering.
Conclusions:
- Bioprinting holds significant potential for cardiac regenerative medicine and diagnostics.
- Further research is needed to overcome current challenges in cardiac tissue engineering and bioprinting.
- Future advancements may lead to more sophisticated and personalized cardiac tissue therapies.

